TP53 and hepatocellular carcinoma: Functional enrichment analysis suggested that berberine exerts its anti-HCC effects mainly by interfering with cell cycle progression, chromosome segregation, and the p53 signaling pathway, indicating that its therapeutic effect is achieved through synergistic targeting of AURKA and CDK1.